Emergent human pathogen simian virus 40 and its role in cancer

Clinical Microbiology Reviews

Volumn 17, Issue 3, 2004, Pages 495-508

  Vilchez, Regis A ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

BONE CANCER; BRAIN CANCER; CANCER; CANCER PATIENT; CANCER RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; HOST CELL; HUMAN; MALIGNANT MESOTHELIOMA; META ANALYSIS; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; REVIEW; SIMIAN VIRUS 40; VIRAL CONTAMINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

NON-PROGRAMMATIC;

HUMANS; NEOPLASMS; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

ANIMALIA; DNA VIRUSES; POLYOMAVIRUS; SIMIAE; SIMIAN VIRUS 40;

EID: 3242761487     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.3.495-508.2004     Document Type: Review

References (135)

1. Arrington, A. S., and J. S. Butel. 2001. SV40 and human tumors, p. 461-489, In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, Inc., New York, N.Y.
2. Ashkenazi, A., and J. L. Melnick. 1962. Induced latent infection of monkeys with vacuolating SV-40 papova virus: virus in kidneys and urine. Proc. Soc. Exp. Biol. Med. 111:367-372.
3. Atwood, W. J. 2001. Cellular receptors for the polyomaviruses, p. 179-196. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, Inc., New York, N.Y.
4. Atwood, W. J., and L. C. Norkin. 1989. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J. Virol. 63:4474-4477.
5. Bergsagel, D. J., M. J. Finegold, J. S. Butel, W. J. Kupsky, and R. L. Garcea. 1992. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med. 326:988-993.
6. Bocchetta, M., I. Di Resta, A. Powers, R. Fresco, A. Tosolini, J. R. Testa, H. I. Pass, P. Rizzo, and M. Carbone. 2000. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl. Acad. Sci. USA 97:10214-10219.
7. Bocchetta, M., L. Miele, H. I. Pass, and M. Carbone. 2003. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 22:81-89.
8. Breau, W. C., W. J. Atwood, and L. C. Norkin. 1992. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J. Virol. 66:2037-2045.
9. Butel, J. S. 2000. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426.
10. Butel, J. S. 2001. Increasing evidence for involvement of SV40 in human cancer. Dis. Markers 17:167-172.
11. Butel, J. S., A. S. Arrington, C. Wong, J. A. Lednicky, and M. J. Finegold. 1999. Molecular evidence of simian virus 40 infections in children. J. Infect. Dis. 180:884-887.
12. Butel, J. S., S. Jafar, C. Wong, A. S. Arrington, A. R. Opekun, M. J. Finegold, and E. Adam. 1999. Evidence of SV40 infections in hospitalized children. Hum. Pathol. 30:1496-1502.
13. Butel, J. S., and J. A. Lednicky. 1999. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91:119-134.
14. Butel, J. S., C. Wong, R. A. Vilchez, Gr. Szücs, I. Dömök, B. Kriz, D. Slonim, and E. Adam. 2003. Detection of antibodies to polyomavirus SV40 in two central European countries. Centr. Eur. J. Public Health 11:3-8.
15. Cacciotti, P., R. Libener, P. Betta, F. Martini, C. Porta, A. Procopio, L. Strizzi, L. Penengo, M. Tognon, L. Mutti, and G. Gaudino. 2001. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc. Natl. Acad. Sci. USA 98:12032-12037.
16. Capello, D., D. Rossi, G. Gaudino, A. Carbone, and G. Gaidano. 2003. Simian virus 40 infection in lymphoproliferative disorders. Lancet 361:88-89.
17. Carbone, M., H. I. Pass, P. Rizzo, M. Marinetti, M. Di Muzio, D. J. Mew, A. S. Levine, and A. Procopio. 1994. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9:1781-1790.
18. Carbone, M., P. Rizzo, A. Procopio, M. Giuliano, H. I. Pass, M. C. Gebhardt, C. Mangham, M. Hansen, D. F. Malkin, G. Bushart, F. Pompetti, P. Picci, A. S. Levine, J. D. Bergsagel, and R. L. Garcea. 1996. SV40-like sequences in human bone tumors. Oncogene 13:527-535.
19. Carbone, M., R. Stach, I. Di Resta, H. I. Pass, and P. Rizzo. 1998. Simian virus 40 oncogenesis in hamsters. Dev. Biol. Stand. 94:273-279.
20. Carroll-Pankhurst, C., E. A. Engels, H. D. Strickler, J. J. Goedert, J. Wagner, and E. A. Mortimer, Jr. 2001. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br. J. Cancer 85:1295-1297.
21. Cicala, C., F. Pompetti, P. Nguyen, K. Dixon, A. S. Levine, and M. Carbone. 1992. SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. Virology 190:475-479.
22. Coe, J. E., and I. Green. 1975. B-cell origin of hamster lymphoid tumors induced by simian virus 40. J. Natl. Cancer Inst. 54:269-270.
23. Cole, C. N., L. V. Crawford, and P. Berg. 1979. Simian virus 40 mutants with deletions at the 3′ end of the early region are defective in adenovirus helper function. J. Virol. 30:683-691.
24. Cole, C. N., and T. P. Stacy. 1987. Biological properties of simian virus 40 host range mutants lacking the COOH-terminus of large T antigen. Virology 161:170-180.
25. Cristaudo, A., A. Vivaldi, G. Sensales, G. Guglielmi, E. Ciancia, R. Elisei, and F. Ottenga. 1995. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40. J. Environ. Pathol. Toxicol. Oncol. 14:29-34.
26. David, H., S. Mendoza, T. Konishi, and C. W. Miller. 2001. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett. 162:57-64.
27. Deminie, C. A., and L. C. Norkin. 1990. Simian virus 40 DNA replication correlates with expression of a particular subclass of T antigen in a human glial cell line. J. Virol. 64:3760-3769.
28. Dhaene, K., A. Verhulst, and E. Van Marck. 1999. SV40 large T-antigen and human pleural mesothelioma: screening by polymerase chain reaction and tyramine-amplified immunohistochemistry. Virchows Arch. Int. J. Pathol. 435:1-7.
29. Diamandopoulos, G. T. 1972. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176:173-175.
30. Diamandopoulos, G. T. 1973. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J. Natl. Cancer Inst. 50:1347-1365.
31. Dolcetti, R., F. Martini, M. Quaia, A. Gloghini, B. Vignocchi, R. Cariati, M. Martinelli, A. Carbone, M. Boiocchi, and M. Tognon. 2003. Simian virus 40 sequences in human lymphoblastoid B-cell lines. J. Virol. 77:1595-1597.
32. Dorries, K. 1997. New aspects in the pathogenesis of polyomavirus-induced disease. Adv. Virus Res. 48:205-261.
33. Dorries, K., G. Loeber, and J. Meixensberger. 1987. Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 160:268-270.
34. Emri, S., T. Kocagoz, A. Olut, Y. Güngen, L. Mutti, and Y. I. Baris. 2000. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res. 20:891-994.
35. Engels, E. A., C. Sarkar, R. W. Daniel, P. E. Gravitt, K. Verma, M. Quezado, and K. V. Shah. 2002. Absence of simian virus 40 in human brain tumors from northern India. Int. J. Cancer 101:348-352.
36. Foddis, R., A. De Rienzo, D. Broccoli, M. Bocchetta, E. Stekala, P. Rizzo, A. Tosolini, J. V. Grobelny, S. C. Jhanwar, H. I. Pass, J. R. Testa, and M. Carbone. 2002. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 21:1434-1442.
37. Fredericks, D. N., and D. A. Reiman. 1996. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9:18-33.
38. Fredricks, D. N., and D. A. Reiman. 1999. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin. Infect. Dis. 29:475-486.
39. Gazdar, A. F., J. S. Butel, and M. Carbone. 2002. SV40 and human tumours: myth, association or causality? Nat. Rev. Cancer 2:957-964.
40. Griffiths, D. J., A. G. Nicholson, and R. A. Weiss. 1998. Detection of SV40 sequences in human mesothelioma. Dev. Biol. Stand. 94:127-136.
41. 2+ND1. J. Virol. 13:1237-1244.
42. Hahn, W. C., S. K. Dessain, M. W. Brooks, J. E. King, B. Elenbaas, D. M. Sabatini, J. A. DeCaprio, and R. A. Weinberg. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:2111-2123.
43. Horvath, L. B. 1972. SV40 neutralizing antibodies in the sera of man and experimental animals. Acta Virol. 16:141-146.
44. Hübner, R., and E. Van Marck. 2002. Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Causes Control 13:121-129.
45. Huff, J. L., and P. A. Barry. 2003. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg. Infect. Dis. 9:246-250.
46. Ibelgaufts, H., and K. W. Jones. 1982. Papovavirus-related RNA sequences in human neurogenic tumours. Acta Neuropathol. 56:118-122.
47. Ilyinskii, P. O., M. D. Daniel, C. J. Horvath, and R. C. Desrosiers. 1992. Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J. Virol. 66:6353-6360.
48. International SV40 Working Group. 2001. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol. Biomarkers Prev. 10:523-532.
49. Jafar, S., M. Rodriguez-Barradas, D. Y. Graham, and J. S. Butel. 1998. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J. Med. Virol. 54:276-284.
50. Jasani, B., A. Cristaudo, S. A. Emri, A. F. Gazdar, A. Gibbs, B. Krynska, C. Miller, L. Mutti, C. Radu, M. Tognon, and A. Procopio. 2001. Association of SV40 with human tumours. Semin. Cancer Biol. 11:49-61.
51. Kelly, T. J., Jr., and A. M. Lewis, Jr. 1973. Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome. J. Virol. 12:643-652.
52. Khalili, K., and G. L. Stoner (ed.). 2001. Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, New York, N.Y.
53. Klein, G., A. Powers, and C. Croce. 2002. Association of SV40 with human tumors. Oncogene 21:1141-1149.
54. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, aud K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
55. Krieg, P., E. Amtmann, D. Jonas, H. Fischer, K. Zang, and G. Sauer. 1981. Episomal simian virus 40 genomes in human brain tumors. Proc. Natl. Nall. Acad. Sci. USA 78:6446-6450.
56. Kwak, E. J., R. A. Vilchez, P. Randbawa, R. Shapiro, J. S. Butel, and S. Kusne. 2002. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin. Infect. Dis. 35:1081-1087.
57. L'Abbe, K. A., A. S. Detsky, and K. O'Rourke. 1987. Meta-analysis in clinical research. Ann. Intern. Med. 107:224-233.
58. Lednicky, J. A., A. S. Arrington, A. R. Stewart, X. M. Dai, C. Wong, S. Jafar, M. Murphey-Corb, and J. S. Butel. 1998. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J. Virol. 72:3980-3990.
59. Lednicky, J. A., and J. S. Butel. 1999. Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front. Biosci. 4:153-164.
60. Lednicky, J. A., and J. S. Butel. 2001. Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin. Cancer Biol. 11:39-47.
61. Lednicky, J. A., and R. L. Garcea. 2001. Detection of SV40 DNA sequences in human tissue. Methods Mol. Biol. 165:257-267.
62. Lednicky, J. A., R. L. Garcea, D. J. Bergsagel, and J. S. Butel. 1995. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212:710-717.
63. Lednicky, J. A., A. R. Stewart, J. J. Jenkins III, M. J. Finegold, and J. S. Butel. 1997. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int. J. Cancer 72:791-800.
64. Lewis, A. M., Jr. 1973. Experience with SV40 and adenovirus-SV40 hybrids, p. 96-113. In A. Hellman, M. N. Oxman, and R. Pollack (ed.), Biohazards in biological research. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
65. Li, J. J., and T. J. Kelly. 1984. Simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 81:6973-6977.
66. Li, R. M., M. H. Branton, S. Tanawattanacharoen, R. A. Falk, J. C. Jennette, and J. B. Kopp. 2002. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol. 13:2320-2330.
67. Li, R. M., R. B. Mannon, D. Kleiner, M. Tsokos, M. Bynum, A. D. Kirk, and J. B. Kopp. 2002. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 74:1497-1504.
68. Lowy, D. R., and P. M. Howley. 2001. Papillomaviruses p. 2231-2264. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, Pa.
69. Lynch, K. J., S. Haggerty, and R. J. Frisque. 1994. D NA replication of chimeric JC virus-simian virus 40 genomes. Virology 204:819-822.
70. MacKenzie, J., K. S. Wilson, J. Perry, A. Gallagher, and R. F. Jarrett. 2003. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J. Natl. Cancer Inst. 95:1001-1003.
71. Malkin, D., S. Chilton-MacNeill, L. A. Meister, E. Sexsmith, L. Diller, and R. L. Garcea. 2001. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 20:4441-4449.
72. Martini, F., L. Iaccheri, L. Lazzarin, P. Carinci, A. Corallini, M. Gerosa, P. Iuzzolino, G. Barbanti-Brodano, and M. Tognon. 1996. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res. 56:4820-4825.
73. Martini, F., L. Lazzarin, L. laccheri, B. Vignocchi, G. Finocchiaro, I. Magnani, M. Serra, K. Scotlandi, G. Barbanti-Brodano, and M. Tognon. 2002. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 94:1037-1048.
74. Meinke, W., D. A. Goldstein, and R. A. Smith. 1979. Simian virus 40-related DNA sequences in a human brain tumor. Neurology 29:1590-1594.
75. Melnick, J. L., and S. Stinebaugh. 1962. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral polio-vaccine. Proc. Soc. Exp. Biol. Med. 109:965-968.
76. Mendoza, S. M., T. Konishi, and C. W. Miller. 1998. Integration of SV40 in human osteosarcoma DNA. Oncogene 17:2457-2462.
77. Milstone, A., R. A. Vilchez, X. Geiger, A. B. Fogo, J. S. Butel Butel, and S. Dummer. 2004. Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient. Transplantation. 77:1019-1024.
78. Minor, P., P. Pipkin, Z. Jarzebek, and W. Knowles. 2003. Studies of neutralising antibodies to SV40 in human sera, J. Med. Virol. 70:490-495.
79. Moore, P. S., and Y. Chang. 1998. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am. J. Epidemiol. 147:217-221.
80. Murakami, Y., C. R. Wobbe, L. Weissbach, F. B. Dean, and J. Hurwitz. 1986. Role of DNA polymerase alpha and DNA primase in simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 83:2869-2873.
81. Newman, J. S., G. B. Baskin, and R. J. Frisque. 1998. Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus monkeys. J. Neurovirol. 4:394-406.
82. Olin, P., and J. Giesecke. 1998. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. Dev. Biol. Stand. 94:227-233.
83. O'Neill, F. J., and D. Carroll. 1981. Amplification of papovavirus detectives during serial low multiplicity infections. Virology 112:800-803.
84. O'Neill, F. J., X. L. Xu, and T. H. Miller. 1990. Host range determinant in the late region of SV40 and RF virus affecting growth in human cells. Intervirology 31:175-187.
85. Pan American Health Organization. 1960. Proceedings of the Second International Conference on Live Poliovirus Vaccines. Scientific Publication no. 50. Pan American Health Organization, Washington, D.C.
86. Pepper, C., B. Jasani, H. Navabi, D. Wynford-Thomas, and A. R. Gibbs. 1996. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 51:1074-1076.
87. Pipas, J. M. 1985. Mutations near the carboxyl terminus of the simian virus 40 large tumor antigen alter viral host range. J. Virol. 54:569-575.
88. Procopio, A., R. Marinacci, M. R. Marinetti, L. Strizzi, D. Paludi, T. Iezzi, G. Tassi, A. Casalini, and A. Modesti, 1998. SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma. Dev. Biol. Stand. 94:361-367.
89. Procopio, A., L. Strizzi, G. Vianale, P. Betta, R. Puntoni, V. Fontana, G. Tassi, F. Gareri, and L. Mutti. 2000. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chrom. Cancer 29:173-179.
90. Rabson, A. S., G. T. O'Conner, L. K. Berezesky, and F. J. Paul. 1964. Enchancement of adenovirus growth in African green monkey kidney cell cultures by SV40. Proc. Soc. Exp. Biol. Med. 116:187-190.
91. Rachlin, J., R. Wollmann, and G. Dohrmann. 1988. Inoculation of simian virus 40 into pregnant hamsters can induce tumors in offspring. Lab. Investig. 58:26-30.
92. Ramael, M., J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer, and C. Van Haesendonck. 1999. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. Eur. Respir. J. 14:1381-1386.
93. Rizzo, P., M. Bocchetta, A. Powers, R. Foddis, E. Stekala, H. I. Pass, and M. Carbone. 2001. SV40 and the pathogenesis of mesothelioma. Semin. Cancer Biol. 11:63-71.
94. Rizzo, P., M. Carbone, S. G. Fisher, C. Matker, L. J. Swinnen, A. Powers, I. Di Resta, S. Alkan, H. I. Pass, and R. I. Fisher. 1999. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 116:4708-4738.
95. Rollison, D. E. M., and K. V. Shah. 2001. The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer, p. 561-584. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses: molecular and clinical perspectives. Wiley-Liss, Inc., New York, N.Y.
96. Sáenz-Robles, M. T., C. S. Sullivan, and J. M. Pipas. 2001. Transforming functions of simian virus 40. Oncogene 20:7899-7907.
97. Shah, K., and N. Nathanson. 1976. Human exposure to SV40: review and comment. Am. J. Epidemiol. 103:1-12.
98. Shah, K. V. 1996. Polyomaviruses, p. 2027-2043. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
99. Shah, K. V., R. W. Daniel, R. F. Zeigel, and G. P. Murphy. 1974. Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation 17:131-134.
100. Sheffield, W. D., J. D. Strandberg, L. Braun, K. Shah, and S. S. Kalter. 1980. Simian virus 40-associated fatal interstitial pneumonia and renal tubular necrosis in a rhesus monkey. J. Infect. Dis. 142:618-622.
101. Shein, H. M., and J. F. Enders. 1962. Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissues. Proc. Soc. Exp. Biol. Med. 109:495-500.
102. Shivapurkar, N., K. Harada, J. Reddy, R. H. Scheuermann, Y. Xu, R. W. McKenna, S. Milchgrub, S. H. Kroft, Z. Feng, and A. F. Gazdar. 2002. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 359:851-852.
103. Shivapurkar, N., T. Wiethege, I. I. Wistuba, S. Milchgrub, K. M. Muller, and A. F. Gazdar. 2000. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int. J. Cancer 85:743-745.
104. Shivapurkar, N., T. Wiethege, I. I. Wistuba, E. Salomon, S. Milchgrub, K. M. Muller, A. Churg, H. Pass, and A. F. Gazdar. 1999. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J. Cell. Biochem. 76:181-188.
105. Spence, S. L., and J. M. Pipas. 1994. SV40 large T antigen functions at two distinct steps in virion assembly. Virology 204:200-209.
106. Spence, S. L., L. C. Tack, J. H. Wright, S. Carswell, and J. M. Pipas. 1990. Infection of CV1 cells expressing the polyoma virus middle T antigen or the SV40 agnogene product with simian virus 40 host-range mutants. In Vitro Cell Dev. Biol. 26:604-611.
107. Srinivasan, M., D. Sedmak, and S. Jewell. 2002. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am. J. Pathol. 161:1961-1971.
108. Stacy, T., M. Chamberlain, and C. N. Cole. 1989. Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression. J. Virol. 63:5208-5215.
109. Stewart, A. R., J. A. Lednicky, U. S. Benzick, M. J. Tevethia, and J. S. Butel. 1996. Identification of a variable region at the carboxy terminus of SV40 large T-antigen, Virology 221:355-361.
110. Stewart, A. R., J. A. Lednicky, and J. S. Butel. 1998. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J. Neurovirol. 4:182-193.
111. Stratton, K., D. A. Almario, and M. C. McCormick. 2003. Immunization safety review: SV40 contamination of polio vaccine and cancer. The National Academies Press, Washington, D.C.
112. Strickler, H. D., J. J. Goedert, S. S. Devesa, J. Lahey, J. F. Fraumeni, Jr., and P. S. Rosenberg. 2003. Trends in U. S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J. Natl. Cancer Inst. 95:38-45.
113. Strickler, H. D., J. J. Goedert, M. Fleming, W. D. Travis, A. E. Williams, C. S. Rabkin, R. W. Daniel, and K. V. Shah. 1996. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol. Biomarkers Prev. 5:473-475.
114. Strickler, H. D., P. S. Rosenberg, S. S. Devesa, J. Hertel, J. F. Fraumeni, Jr., and J. J. Goedert. 1998. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279:292-295.
115. Strizzi, L., G. Vianale, M. Giuliano, R. Sacco, F. Tassi, P. Chiodera, P. Casalini, and A. Procopio. 2000. SV40, JC and BK expression in tissue, urine and blood samples from patients with malignant and nonmalignant pleural disease. Anticancer Res. 20:885-889.
116. Sullivan, C. S., and J. M. Pipas. 2002. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66:179-202.
117. Suzuki, S. O., M. Mizoguchi, and T. Iwaki. 1997. Detection of SV40 T antigen genome in human gliomas. Brain Tumor Pathol. 14:125-129.
118. Tornow, J., and C. N. Cole. 1983. Nonviable mutants of simian virus 40 with deletions near the 3′ end of gene A define a function for large T antigen required after onset of viral DNA replication. J. Virol. 47:487-494.
119. Tornow, J., M. Polvino-Bodnar, G. Santangelo, and C. N. Cole. 1985. Two separable functional domains of simian virus 40 large T antigen: carboxyl-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis. J. Virol. 53:415-424.
120. Toyooka, S., H. I. Pass, N. Shivapurkar, Y. Fukuyama, R. Maruyama, K. O. Toyooka, M. Gilcrease, A. Farinas, J. D. Minna, and A. F. Gazdar. 2001. Aberrant methylation and simian virus 40 Tag sequences in malignant mesothelioma. Cancer Res. 61:5727-5730.
121. Vilchez, R. A., and J. S. Butel. 2003. SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene 22:5164-5172.
122. Vilchez, R. A., C. A. Kozinetz, A. S. Arrington, C. R. Madden, and J. S. Butel. 2003. Simian virus 40 in human cancers. Am. J. Med. 114:675-684.
123. Vilchez, R. A., C. A. Kozinetz, and J. S. Butel. 2003. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol. 4:188-191.
124. Vilchez, R. A., J. A. Lednicky, S. J. Halvorson, Z. S. White, C. A. Kozinetz, and J. S. Butel. 2002. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J. Acquir. Immune Defic. Syndr. 29:109-116.
125. Vilchez, R. A., C. R. Madden, C. A. Kozinetz, S. J. Halvorson, Z. S. White, J. L. Jorgensen, C. J. Finch, and J. S. Butel. 2002. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359:817-823.
126. Viscidi, R. P., D. E. M. Rollison, E. Viscidi, B. Clayman, E. Rubalcaba, R. Daniel, E. O. Major, and K. V. Shah. 2003. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 10:278-285.
127. Waga, S., G. Bauer, and B. Stillman. 1994. Reconstitution of complete SV40 DNA replication with purified replication factors. J. Biol. Chem. 269:10923-10934.
128. Weggen, S., T. A. Bayer, A. Koch, H. Salewski, K. H. Scheidtmann, T. Pietsch, and O. D. Wiestler. 1997. Characterization of neural cell lines derived from SV40 large T-induced primitive neuroectodermal tumors. Brain Pathol. 7:731-739.
129. Weggen, S., T. A. Bayer, A. Von Deimling, G. Reifenberger, D. Von Schweinitz, O. D. Wiestler, and T. Pietsch. 2000. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. 10:85-92.
130. Weiss, A. F., R. Portmann, H. Fischer, J. Simon, and K. D. Zang. 1975. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc. Natl. Acad. Sci. USA 72:609-613.
131. Wong, M., J. S. Pagano, J. T. Schiller, S. S. Tevethia, N. Raab-Traub, and J. Gruber. 2002. New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer. J. Natl. Cancer Inst. 94:1832-1836.
132. Yamamoto, H., T. Nakayama, H. Murakami, T. Hosaka, T. Nakamata, T. Tsuboyama, M. Oka, T. Nakamura, and J. Toguchida. 2000. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br. J. Cancer 82:1677-1681.
133. Zhen, H. N., X. Zhang, X. Y. Bu, Z. W. Zhang, W. J. Huang, P. Zhang, J. W. Liang, and X. L. Wang. 1999. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 86:2124-2132.
134. Zimmermann, W., S. Scherneck, and E. Geissler. 1983. Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA). Zentralbl. Bakteriol. Mikrobiol. Hyg. 254:187-196.
135. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.